Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...
Drug Delivery Business

Insulet to launch next-gen Omnipod 6 in 2027, outlines plans for fully closed loop pump for type 2

Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system.
Le Lézard

Appian Names 2025 Public Sector Partner Award Winners

At this year's Appian Government conference, Appian announced the winners of its 2025 Appian Government Partner Impact and Excellence Awards. These annual awards celebrate Appian partners for ...